polyvalent melanoma vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016175
A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death.
| Identifier | MLC-T-ONC-016175 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PMCV |
| Synonyms | polyvalent melanoma cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016175",
"term": "polyvalent melanoma vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death.",
"abbreviation": "PMCV",
"synonyms": [
"polyvalent melanoma cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/polyvalent-melanoma-vaccine/"
}
Record 13,478 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.